Wolverine Trading’s DarioHealth DRIO Stock Holding History

Wolverine Trading’s Portfolio DRIO Stock Details DRIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1,175	Closed	-$101K	–	4391
2022 Q4	$101K	Sell	1,175 -345	-23%	-$31.1K	﹤0.01%	3408
2022 Q3	$136K	Buy	+1,520	New	+$163K	﹤0.01%	3794

Other funds holding DRIO

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

AWAM

Appian Way Asset Management New York $558M AUM 1.95% 1-Year Est. Return

YDMI

Y.D. More Investments Ramat Gan, Israel $2.55B AUM 104.35% 1-Year Est. Return

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wolverine Trading's DRIO Position: Q3 2023 in Review

Wolverine Trading sold out of DarioHealth (DRIO) in Q3 2023, closing a stake of 682 shares — an estimated $54.6K sold.

Wolverine Trading first reported a position in DRIO in Q3 2022 and held it in 4 quarters. The position peaked at $100K in Q3 2022. 41 funds tracked by Wall St. Rank hold DRIO as of Q3 2023.

Wolverine Trading reported no remaining DarioHealth position as of Q3 2023 after selling out during the quarter.
Wolverine Trading sold 682 DarioHealth shares in Q3 2023, an estimated $54.6K.
Wolverine Trading first reported a position in DarioHealth in Q3 2022 and held it in 4 quarters.
Wolverine Trading's DarioHealth position peaked at $100K in Q3 2022.
41 funds tracked by Wall St. Rank held DarioHealth as of Q3 2023.

Based on Wolverine Trading's 13F filing for Q3 2023, filed 15 Nov 2023.